Nine months ended 30 Sep


Key Consolidated Statement of
Comprehensive Income Items
2021
US$ mn

(unaudited)
2020
US$ mn
(restated)
(unaudited)
     
Revenue 3,305 3,200
Gross Profit 645 994
Share of Profit/(Loss) of a 35%-owned Associate - CTI (64) -
Profit/(Loss) Attributable to Shareholders (17) 496
Profit Attributable to Shareholders before Biological Assets Fair Value Changes 110 502
     
     
     
  As at 30 Sep
2021
As at 31 Dec
2020
Key Consolidated Statement of
Financial Position Items
(unaudited)
US$ mn
(audited)
US$ mn
     
Property, Plant & Equipment 1,684 1,589
Investment in Associates 2,185 2,331
Total Assets 6,613 6,597
Bank and Other Borrowings 1,384 1,136
Issued Capital 253 253
Shareholders' Equity 3,248 3,548
Total Equity 3,597 4,033